Cell proliferation assays confirmed a significant additional increase after concomitant treatment with IL-6 and IL-10, suggesting that IL-10 works in tandem with IL-6 to sustain MM cell proliferation, while neutralizing antibodies markedly reduced the rate of proliferation of MM cells (Fig. 5D). Here, IL6 is linked to Miyoshi myopathy.